Nigeria Centre for Disease Control on Tuesday reported one COVID-19 death and 156 new infections in 11 states.
The death toll from the disease in Nigeria has reduced recently with only two fatalities recorded in about two weeks.
With one new death on Tuesday, the fatality toll rose to 2,063 in total, according to an update published by NCDC on Tuesday night.
According to NCDC, the 156 new cases were reported from 11 states: Lagos-50, Enugu-43, Adamawa-40, FCT-8, Ogun-5, Akwa Ibom-3, Plateau-3, Jigawa-1, Kaduna-1, Oyo-1 and Rivers-1.
With the new cases, Nigeria has recorded a total of 164,912 infections as at April 27.
156 new cases of #COVID19Nigeria;
Lagos-50
Enugu-43
Adamawa-40
FCT-8
Ogun-5
Akwa Ibom-3
Plateau-3
Jigawa-1
Kaduna-1
Oyo-1
Rivers-1164,912 confirmed
155,012 discharged
2,063 deaths@Chikwe_I @WHONigeria @nighealthwatch @PTFCOVID19 @NOA_Nigeria @Fmohnigeria @FMICNigeria pic.twitter.com/JOox4LpB1Z— NCDC (@NCDCgov) April 27, 2021
In addition, a breakdown of NCDC’s data shows that 434 persons were discharged on Tuesday after testing negative for the COVID-19 virus following treatment, bringing the total number of discharged persons to 155,012.
Today’s report include:
✅Data from Enugu State are recorded on the 20th- 26th of April, 2021.
✅Adamawa State cases are recorded over the period of two weeks.
A breakdown of cases by state via https://t.co/zQrpNeOfet pic.twitter.com/3QZg7FLSpS
— NCDC (@NCDCgov) April 28, 2021
There are still 9,900 active COVID-19 infections in the country, as at the time of filing this report.
Since the pandemic broke out in Nigeria in February 2020, the country has carried out 1,912,628 million tests, according to NCDC.
Meanwhile, Nigeria commenced vaccination in early March beginning with healthcare workers. Over one million people have since been vaccinated.
Federal government has said it plans to vaccinate 109 million people against the COVID-19 virus over a period of two years.
Health authorities said only eligible population from 18 years and above will be vaccinated in four phases.
It would be recalled that Nigeria received approximately 4.4 million doses of AstraZeneca COVID-19 vaccines in March, which is quite insufficient considering the target of its population eligible for vaccination in the first phase.
Due to limited doses of vaccine available, the government recently directed states to halt vaccination once they use half of the doses allocated to them.
“We are aware of the global scarcity of COVID-19 vaccines due to high demands especially in countries where vaccines are being produced,” head of Nigeria’s immunisation Agency, Faisal Shuaib, said at a briefing of the Presidential Steering Committee (PSC) on Monday.
Shuaib said the government anticipates a delay in vaccine supply which may also affect and impact the remaining phases of the vaccination campaign.
He also revealed that the country expects to receive about 29.8 million doses of l Johnson & Johnson (J&J) COVID-19 vaccines, which requires the administering of just a single shot.
The vaccine is compatible with standard vaccine storage and distribution channels with ease of delivery to remote areas.
